Neutralizing the EGF receptor in glioblastoma cells stimulates cell migration by activating uPAR-initiated cell-signaling

In glioblastoma (GBM), the EGF receptor (EGFR) and Src family kinases (SFKs) contribute to an aggressive phenotype. EGFR may be targeted therapeutically; however, resistance to EGFR-targeting drugs such as Erlotinib and Gefitinib develops quickly. In many GBMs, a truncated form of the EGFR (EGFRvIII...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Oncogene
Hlavní autoři: Hu, Jingjing, Muller, Karra A., Furnari, Frank B., Cavenee, Webster K., VandenBerg, Scott R., Gonias, Steven L.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2014
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4411189/
https://ncbi.nlm.nih.gov/pubmed/25347738
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/onc.2014.336
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky